Table 1.
Clinicopathological features of the 152 patients with MTC.
| Characteristic | Value |
|---|---|
| Gender male/female (n) | 59/93 (38.8%/61.2%) |
| Age (years) | 46.5 ± 12.3 (range, 19 to 77) |
| BMI (kg/m2) | 23.5 (21.0−25.5) |
| Symptomatic (n) | 36 (23.7%) |
| Subtype (n) | |
| Sporadic MTC | 125 (82.2%) |
| Hereditary MTC | 27 (17.8%) |
| Surgery pattern (n) | |
| TT with central LND | 67 (44.1%) |
| TT with central and lateral LND | 85 (55.9%) |
| Multifocal tumor (n) | 43 (28.3%) |
| Bilateral lobes tumor (n) | 39 (25.7%) |
| Central LNM (n) | 79 (52.0%) |
| Lateral LNM (n) | 65 (42.8%) |
| Tumor staging (n) | |
| I | 41 (27.0%) |
| II | 19 (12.5%) |
| III | 23 (15.1%) |
| IV | 69 (45.4%) |
MTC: medullary thyroid carcinoma; BMI: body mass index; TT: total thyroidectomy; LND: lymph node dissection; LNM: lymph node metastases.